Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colorectal Neoplasms × Uracil × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 266 Bevacizumab 255 Fluorouracil 247 Irinotecan 239 Leucovorin 215 Capecitabine 192 Cetuximab 160 Colonoscopy 74 Folfox protocol 67 Panitumumab 64 regorafenib 62 Radiotherapy 50 Drug Therapy 50 HMPL-013 49 Blood Specimen Collection 45 trifluridine tipiracil drug combination 43 pembrolizumab 40 Surveys and Questionnaires 35 Standard of Care 34 Neoadjuvant Therapy 34 Surgical Procedures, Operative 33 Nivolumab 32 Magnetic Resonance Spectroscopy 29 IFL protocol 27 Trifluridine 26 Interviews as Topic 26 Celecoxib 26 XELOX 24 Early Intervention, Educational 24 Methods 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01225744 2014-06-11

eSCOUT

The Christie NHS Foundation Trust

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡